These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 786872)

  • 1. Comparative bioavailability of drug products: principles, design of study and data analysis.
    Nanivadekar AS; Gupta PD; Kulkarni SS
    Indian J Med Res; 1976 Apr; 64(4):545-53. PubMed ID: 786872
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical inference as applied to bioavailability data--a guide for the practicing pharmacist.
    Bennett RW; Popovich NG
    Am J Hosp Pharm; 1977 Jul; 34(7):712-23. PubMed ID: 578074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical problems in interpreting comparative bioavailability trials.
    Westlake WJ
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):342-5. PubMed ID: 1099025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bioavailability data by practitioners. I: pitfalls in interpreting the data.
    Schumacher GE
    Am J Hosp Pharm; 1975 Aug; 32(8):639-42. PubMed ID: 1146833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability studies and the clinical pharmacologist: correlation of drug distribution with clinical effects.
    Ogilvie RI
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):349-54. PubMed ID: 1099026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of three brands of ampicillin.
    MacLeod C; Rabin H; Ruedy J; Caron M; Zarowny D; Davies RO
    Can Med Assoc J; 1972 Aug; 107(3):203-9. PubMed ID: 5052904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacist's ability to use bioavailability data.
    Cronk JD; Williams RB; Moore WE
    Am J Hosp Pharm; 1975 Jan; 32(1):46-8. PubMed ID: 1124781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical aspects of comparative bioavailability trials.
    Westlake WJ
    Biometrics; 1979 Mar; 35(1):273-80. PubMed ID: 583027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 12. Statistical interpretation of bioavailability data.
    Bennett RW; Popovich NG
    Am J Hosp Pharm; 1978 Aug; 35(8):902. PubMed ID: 677134
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
    Cabana BE
    Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of balanced incomplete block designs in comparative bioavailability trails.
    Westlake WJ
    Biometrics; 1974 Jun; 30(2):319-27. PubMed ID: 4833141
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Bioavailability data--useful or useless?
    Feldmann EG
    J Pharm Sci; 1975 Sep; 64(9):I. PubMed ID: 1185555
    [No Abstract]   [Full Text] [Related]  

  • 17. Assurance of drug quality (bioavailability).
    Coleman JH; Straughn AB
    Dis Nerv Syst; 1975 Feb; 36(2):63-4. PubMed ID: 1116416
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical questions on bioavailability and proff of efficacy (author's transl)].
    Gillmann H
    Arzneimittelforschung; 1976; 26(1A):103-4. PubMed ID: 947189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the clinical inequivalency of drug products of varying bioavailability.
    Barr WH; Adir J
    Ann Clin Res; 1974; 6(0):suppl 11:48-56. PubMed ID: 4605465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of manufacturing and storage conditions on the bioavailability of pharmaceuticals].
    Jaminet F
    Bull Mem Acad R Med Belg; 1976; 131(3-4-5):149-59. PubMed ID: 1021199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.